Immundeficiency 83 D84.-

Last updated on: 10.04.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Immunodeficiency-83 (IMD83) is characterized by increased susceptibility to severe viral infections, including herpes simplex virus (HSV), varicella zoster virus (VZV), influenza A virus (IAV), hantavirus, and possibly respiratory syncytial virus (RSV). Causally, the disease is due to a mutaion in the TLR3 gene .The age of onset varies widely from infancy to adulthood, and there is incomplete penetrance.

EtiopathogenesisThis section has been translated automatically.

Susceptibility to encephalitis or pneumonia appears to result from impaired TLR3-dependent interferon production by non-hematopoietic cells located in the CNS or lung epithelial cells (Zhang et al. 2013; Mork et al. 2015; Sironi et al. 2017, Lim et al. 2019)

LiteratureThis section has been translated automatically.

  1. Lim HK et al (2019) Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med 216: 2038-2056.
  2. Mork N et al (2015) Mutations in the TLR3 signaling pathway and beyond in adult patients with herpes simplex encephalitis. Genes Immun 16: 552-566.
  3. Sironi M et al (2015) TLR3 mutations in adult patients with herpes simplex virus and varicella-zoster virus encephalitis. J Infect Dis 215: 1430-1434.
  4. Zhang S-Y et al (2013) TLR3 immunity to infection in mice and humans. Curr. Opin. Immunol. 25: 19-33.

Last updated on: 10.04.2022